deltatrials
Completed NA INTERVENTIONAL 3-arm NCT02097030

Clinical Evaluation of Daily Disposable Contact Lenses

Single-Center Clinical Evaluation of Daily Disposable Contact Lenses

Sponsor: CooperVision, Inc.

Conditions Myopia
Updated 9 times since 2017 Last updated: Jul 19, 2020 Started: Mar 31, 2014 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Myopia and is currently completed. CooperVision, Inc. leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2020 · 26 months · monthly snapshotCompleted~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotCompleted~Jan 2025 – ~May 2025 · 4 months · monthly snapshotCompleted~May 2025 – present · 14 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. May 2025 — Present [monthly]

    Completed NA

  2. Jan 2025 — May 2025 [monthly]

    Completed NA

  3. Sep 2024 — Jan 2025 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jul 2024 [monthly]

    Completed NA

Show 4 earlier versions
  1. Aug 2020 — Jan 2021 [monthly]

    Completed NA

    Phase: PHASE4NA

  2. Jun 2018 — Aug 2020 [monthly]

    Completed PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CooperVision, Inc.
Data source: CooperVision International Limited (CVIL)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations